Published on behalf of the British Pharmacological Society, the British Journal of Clinical Pharmacology (BJCP) reports on all aspects of drug action in man.
Find out more at About the Journal including:
Author Services
Online Submission
Editors' Views FREE online
To find out more about BJCP's sister journal, British Journal of Pharmacology (BJP), click here
BJCP's latest Impact Factor is now 3.246
Thomson Reuters Science Citation Index 2009
57/216 (Pharmacology & Pharmacy)
_______________________________________________________
BJCP Press Releases
Find out more by visiting our press room.
For general information, please email jbeal@wiley.com.
_______________________________________________________
21st January:
IMPACT OF ‘GET RANDOMISED’ CAMPAIGN IN SCOTLAND
_______________________________________________________
BJCP – Just Published
Read the latest issue...
_______________________________________________________
Click here to access now.
_______________________________________________________
BJCP cancer drug research articles
Free access to some of the top recent cancer papers from BJCP.
Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects.
Deborah A. Smith, Kevin M. Koch, et al.
Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.
Corine Ekhart, Valerie D. Doodeman, et al.
Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.
Ahmed F. Hawwa, Paul S. Collier, et al.
Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.
Ahmed F. Hawwa, Jeff S. Millership, et al.
Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin.
Anthe S. Zandvliet, Jan H. M. Schellens, et al.
Nail and periungual toxicity following capecitabine therapy.
Mario Vaccaro, Olga Barbuzza, et al.
Candidate mechanisms for capecitabine-related hand–foot syndrome.
Gérard Milano, Marie-Christine Etienne-Grimaldi, et al.
Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients.
Christa E. Nath, John W. Earl, et al.
The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
Barrett W. Newsome, Marc S. Ernstoff
A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient.
Hélène Blasco, Michéle Boisdron-Celle, et al.
Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia.
Yanfeng Wang, Li Zhou, Catherine Dutreix, et al.
Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.
Franck Bürki, Kattalin Badie, et al.
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized study.
Etienne G. C. Brain, Kevan Rezai, et al.
Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate.
Xuemin Jiang, Peter Galettis, et al.
Serious haematological toxicity of cyclophosphamide in relation to CYP2B6, GSTA1 and GSTP1 polymorphisms.
Agnès Tran, François Bournerias, et al.
________________________________________________________
BJCP content relevant for prescribing and medicines management
Free access to some of the latest BJCP papers relevant to prescribing and medicines management.
_______________________________________________________
Prescribing in pregnancy and lactation.
E. J. Begg
Assessing general practitioners' prescribing behaviour in elderly patients with concealed renal failure.
Annie Pierre Jonville-Béra, Lucie Paroux, Elisabeth Autret-Leca
Candidate mechanisms for capecitabine-related hand–foot syndrome.
Gérard Milano, et al
Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials.
Liam Smeeth, Ian Douglas, Andrew J. Hall, Richard Hubbard, Stephen Evans
Suggestions for effective contraception in isotretinoin therapy.
Antonios I. Kanelleas, Steve Thornton, John Berth-Jones
________________________________________________________
BJCP content relevant for industry
Free access to some of the latest BJCP papers relevant to industry.
_______________________________________________________
Drug regulation & therapeutic efficacy.
J. M. Ritter
Thrombolysis or nothing for acute myocardial infarction? It's all the same!
Vittorio Bertele, Laura Angelici, Simona Barlera, Silvio Garattini
The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
Barrett W. Newsome, Marc S. Ernstoff
Candidate mechanisms for capecitabine-related hand–foot syndrome.
Gérard Milano, et al
A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.
Jennifer Peppe, Andrew Porzio, David M. Davidson
Variability in the quality of overdose advice in Summary of Product Characteristics (SPC) documents: gut decontamination recommendations for CNS drugs.
Andrew J. B. Wall, D. N. Bateman, W. S. Waring
________________________________________________________
British Pharmacological Society (BPS)
NEWS
________________________________________________________
Increased Impact factors for both BPS journals
We are delighted to announce that the Impact Factor for BJP has increased to 5.204*, according to ISI citation data.
This confirms BJP as the highest ranked general pharmacology research journal (now ranked 19th in the ISI Pharmacology & Pharmacy category*) and reinforces BJP's position as the place authors and readers go for high impact research across the spectrum of pharmacology.
There is also good news for British Journal of Clinical Pharmacology, which has an increased Impact Factor for 2009 of 3.246*, building on last year's important achievement of reaching a value above 3.
We would like to thank the Editors, our reviewers and those authors who chose the BPS journals as the home for their high quality work, for their valuable contributions towards reaching these excellent Impact Factor scores.
* Thomson Reuters Science Citation Index 2009
BPS Meetings
Find out more on the BPS Meetings page.
14-16 December 2010
BPS Winter Meeting, London 2010
Queen Elizabeth II Conference Centre, London
For more information please contact the BPS Meetings Team
